WEITZMAN DEBORAH (CEO, Pharmaceutical Segment) sold 8.6% of their position (7.35K shares) of CARDINAL HEALTH INC on the open market
Open‑market sale worth $1.73M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/20/2026ACC: 0001942639-26-000003
Officer· CEO, Pharmaceutical Segment
Since Sep 2022
-7.35K
Net shares
Net seller
$1.73M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
7.35K disposed
Non-Derivative Transactions3
Common Shares
Direct
Shares
−6.67K
Price / share
$235.30
Trade value
$1.57M
% of position
7.8%
8/18/2026
85.25K→78.59K
Common Shares
Direct
Shares
−408.00
Price / share
$236.59
Trade value
$96.53K
% of position
0.5%
8/18/2026
78.59K→78.18K
Common Shares
Direct
Shares
−281.00
Price / share
$237.44
Trade value
$66.72K
% of position
0.4%
8/18/2026
78.18K→77.90K
Total
Net shares
−7.35K
Net value
-$1.73M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 8/18/2026 | S · Sale | −6.67K | $235.30 | $1.57M | 7.8% | 85.25K | 78.59K |
| Common Shares Direct | 8/18/2026 | S · Sale | −408.00 | $236.59 | $96.53K | 0.5% | 78.59K | 78.18K |
| Common Shares Direct | 8/18/2026 | S · Sale | −281.00 | $237.44 | $66.72K | 0.4% | 78.18K | 77.90K |
| Total | −7.35K | -$1.73M | ||||||
Derivative Transactions0
No derivative transactions reported